RE:RE:RE:Gate Keeper ?There has been no negative news but according to Mr. Seto, the 90 patient enrolment milestone was expected to be a major catalyst and it simply wasn't.
I think the drop was because of disappointed expectations. Nothing negative was announced - Baxter maintained distribution rights, the trial is continuing as before and Dr. Kellum is very pleased with the results as before.
But Baxter chose not to look at the raw data and it doesn't seem we will get any results update until the end of the trial.
So...nothing to see here yet.
Upcoming catalysts will be the Vantive launch, (or Baxter sell off of it's Kidney Care business). a projected Tigris completion by the end of 2024 and approval and the start of commercialization by the end of 2025.
There is also the possibility of a buyout by Baxter, Vantive or somebody else. But this is just speculation.
So there may be no dramatic sp action in the near term and those who got in with the expectation of significant sp appreciation are falling away and the sp is settling back down to it's previous comfort level.
Accountprince wrote: Gerry you are on the right track. While the Three Stooges were demonstrating their Stoopidity the price was manipulated down to .40. There has been no negative news yet we're down by .27 per share since we hit interim of 90 patients. What logic is there to support that drop? Three incoherent flunkies foaming nonsense at the mouth? Or an orchestrated program to bring it down while the fools attempt to cover?
how can success result in a 40% decline in the share price? How can a single respected poster get thrown out for no reason and for nothing done in the last five years? Hoping to be wrong but it happens when the intent is to issue cheap shares to friends and family. Even worse when you issue cheap options to management and those who are supposed to be governance. If anything issued below the .67 a share that proves my assertion. EOM